Inferior outcomes seen in elderly patients with HL
2 years ago
[{"url":"https://i.ytimg.com/vi/F8iMJcIWqCs/hq720.jpg?sqp=-oaymwE2COgCEMoBSFXyq4qpAygIARUAAIhCGAFwAcABBvABAfgB1AaAAuADigIMCAAQARhUIGUoZTAP&rs=AOn4CLDguVKi5L0fiiiUiCsANMQb-x9-pA","width":360,"height":202},{"url":"https://i.ytimg.com/vi/F8iMJcIWqCs/hq720.jpg?sqp=-oaymwE2CNAFEJQDSFXyq4qpAygIARUAAIhCGAFwAcABBvABAfgB1AaAAuADigIMCAAQARhUIGUoZTAP&rs=AOn4CLDeysQhWihhZjiRIfAciTZA_gOAhA","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/F8iMJcIWqCs/mqdefault_6s.webp?du=3000&sqp=CKD4sKkG&rs=AOn4CLAB-t5Kq3S_jBMkbo8xlohjr8_mAg","width":320,"height":180}
[{"text":"Jonathan Friedberg, MD, University of Rochester, Rochester, NY, explores why elderly patients with Hodgkin lymphoma (HL)\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Inferior outcomes seen in elderly patients with HL by VJHemOnc \u2013 Video Journal of Hematological Oncology 35 views 2 years ago 1 minute, 38 seconds","duration":"1 minute, 38 seconds"}